A genome-wide investigation of SNPs and CNVs in schizophrenia AC Need, D Ge, ME Weale, J Maia, S Feng, EL Heinzen, KV Shianna, ... PLoS genetics 5 (2), e1000373, 2009 | 558 | 2009 |
Serotonin subtype 2 receptor genes and clinical response to clozapine in schizophrenia patients M Masellis, V Basile, HY Meltzer, JA Lieberman, S Sevy, FM Macciardi, ... Neuropsychopharmacology 19 (2), 123-132, 1998 | 320 | 1998 |
Cost effectiveness of clozapine in neuroleptic-resistant schizophrenia HY Meltzer, P Cola, L Way, PA Thompson, B Bastani, MA Davies, B Snitz American Journal of Psychiatry 150, 1630-1630, 1993 | 287 | 1993 |
Age at onset and gender of schizophrenic patients in relation to neuroleptic resistance HY Meltzer, J Rabinowitz, MA Lee, PA Cola, R Ranjan, RL Findling, ... American Journal of Psychiatry 154 (4), 475-482, 1997 | 235 | 1997 |
Marked elevations of serum creatine kinase activity associated with antipsychotic drug treatment HY Meltzer, PA Cola, M Parsa Neuropsychopharmacology 15 (4), 395-405, 1996 | 219 | 1996 |
Association study between the dopamine D4 receptor gene and schizophrenia A Petronis, F Macciardi, A Athanassiades, AD Paterson, M Verga, ... American journal of medical genetics 60 (5), 452-455, 1995 | 76 | 1995 |
Frequency analysis of large CAG/CTG trinucleotide repeats in schizophrenia and bipolar affective disorder. JB Vincent, T Klempan, SS Parikh, T Sasaki, HY Meltzer, G Sirugo, P Cola, ... Molecular psychiatry 1 (2), 141-148, 1996 | 72 | 1996 |
The pharmacoeconomics of clozapine: a review. HY Meltzer, PA Cola The Journal of clinical psychiatry 55, 161-165, 1994 | 72 | 1994 |
Relapse following clozapine withdrawal: effect of neuroleptic drugs and cyproheptadine HY Meltzer, MA Lee, R Ranjan, EA Mason, PA Cola Psychopharmacology 124, 176-187, 1996 | 68 | 1996 |
The evolution of treatment resistance: biologic implications HY Meltzer, M Lee, P Cola Journal of clinical psychopharmacology 18 (2), 5S-11S, 1998 | 49 | 1998 |
Plasma clozapine and desmethylclozapine levels in clozapine-induced agranulocytosis M Hasegawa, PA Cola, HY Meltzer Neuropsychopharmacology 11 (1), 45-47, 1994 | 47 | 1994 |
A randomized trial comparing clozapine and typical neuroleptic drugs in non-treatment-resistant schizophrenia HY Meltzer, WV Bobo, MA Lee, P Cola, K Jayathilake Psychiatry research 177 (3), 286-293, 2010 | 35 | 2010 |
Dopamine and serotonin system genes may predict clinical response to clozapine F Badri, M Masellis, A Petronis, FM Macciardi, HHM Van Tol, P Cola, ... Am J Hum Genet 59 (4), A247, 1996 | 34 | 1996 |
Coping with diabetes: Provider attributes that influence type 2 diabetes adherence Y Freeman-Hildreth, D Aron, PA Cola, Y Wang PloS one 14 (4), e0214713, 2019 | 25 | 2019 |
Clozapine vs. haloperidol: antipsychotic effects on sexual function in schizophrenia L Covington, PA Cola Sexuality and Disability 18, 41-48, 2000 | 24 | 2000 |
Responsible research: A guide for coordinators PA Cola, C Pierre Remedica, 2006 | 23 | 2006 |
Systems-savvy selling, interpersonal identification with customers, and the sales manager’s motivational paradox: a constructivist grounded theory approach. DP St. Clair, GK Hunter, PA Cola, RJ Boland Journal of Personal Selling & Sales Management, 1-22, 2018 | 21 | 2018 |
Evaluating various areas of process improvement in an effort to improve clinical research: discussions from the 2012 Clinical Translational Science Award (CTSA) Clinical … JE Strasser, PA Cola, D Rosenblum Clinical and translational science 6 (4), 317-320, 2013 | 21 | 2013 |
Perspectives of individuals with multiple sclerosis on discontinuation of disease-modifying therapies MP McGinley, PA Cola, RJ Fox, JA Cohen, JJ Corboy, D Miller Multiple Sclerosis Journal 26 (12), 1581-1589, 2020 | 18 | 2020 |
Research participant‐centered outcomes at NIH‐supported clinical research centers RG Kost, LN Lee, JL Yessis, R Wesley, S Alfano, SR Alexander, ... Clinical and translational science 7 (6), 430-440, 2014 | 16 | 2014 |